Pulmonary metastatic sarcomas: prognostic relevance of imaging information at baseline and during follow up

Pulmonary metastatic sarcomas: prognostic relevance of imaging information at baseline and during follow up - Pulmonary metastatic sarcomas

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028706

Enrollment

100

Registered

2023-02-16

Start date

2022-05-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C49.8

Interventions

Group 1: Retrospective data analysis of patients diagnosed with sarcoma and pulmonary metastasis.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Diagnosis of Sarkoma - Pulmonalary Metastasis - Active Treatment - Imaging before treatment available (=4 weeks) as well as during treatment - Documented OS

Exclusion criteria

Exclusion criteria: - Non-diagnostic quality - Limitation of metastatic assessment due to overlaying pathology

Design outcomes

Primary

Measure	Time frame
Association of imaging parameters with Overall Survival(OS)	—

Secondary

Measure	Time frame
Association of imaging parameters with Progression Free Survival (PFS)	—

Countries

Germany

Contacts

Public ContactWolfgang Kunz

Klinikum der Universität München

Wolfgang.Kunz@med.uni-muenchen.de+49 89 4400-73620

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026